Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc (KNSA), sold 167,703 shares at $27.33 ($4.6M) on 2025-05-28, disclosed to the SEC on 2025-05-28.
Scheduled sale ($4.6M) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 4,837 | $131K | 2.9% |
| 2 | $27.01 | 19,317 | $522K | 11.4% |
| 3 | $27.01 | 19,317 | $522K | 11.4% |
| 4 | $27.33 | 62,116 | $1.7M | 37.2% |
| 5 | $27.33 | 62,116 | $1.7M | 37.2% |
| Total | $27.25 avg | 167,703 |
| $4.6M |
| 100% |
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-22 | $127K | — | Filing → |